Evidence map›Paper›PMID 26694585›Full record

ArticleImmunology2016

Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation.

Julia Böhme, Caroline Roßnagel, Thomas Jacobs, Jochen Behrends, Christoph Hölscher, Hanna Erdmann

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Whole blood transcriptome analysis in onchocerciasis.Current research in parasitology & vector-borne diseases · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Understanding CD8Trends in parasitology · 2019
    Review
  7. The ORMDL3 Asthma Gene Regulates ICAM1 and Has Multiple Effects on Cellular Inflammation.American journal of respiratory and critical care medicine · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Ebi3 PreventsFrontiers in immunology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Julia BöhmeInfection Immunology, Research Centre Borstel, Borstel, Germany.
Caroline RoßnagelInfection Immunology, Research Centre Borstel, Borstel, Germany.
Thomas JacobsDepartment of Immunology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
Jochen BehrendsInfection Immunology, Research Centre Borstel, Borstel, Germany.
Christoph HölscherInfection Immunology, Research Centre Borstel, Borstel, Germany.
Hanna ErdmannInfection Immunology, Research Centre Borstel, Borstel, Germany.
Research Center Borstel - Leibniz Lung Center · DEBernhard Nocht Institute for Tropical Medicine · DEClinical Research Center Kiel · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Epstein-Barr virus-induced gene 3 (EBI3) is a member of the interleukin-12 (IL)-12) family structurally related to the subunit p40 of IL-12 and forms a heterodimer either with the p28 subunit to build IL-27 or with p35 to form IL-35. Interleukin-27 is secreted by antigen-presenting cells whereas IL-35 appears to be produced mainly by regulatory T cells and regulatory B cells but both cytokines negatively regulate inflammatory immune responses. We here analysed the function of EBI3 during infection with the intracellular parasite Trypanosoma cruzi. Compared with C57BL/6 wild-type mice, EBI3-deficient (EBI3(-/-) ) mice showed a higher parasitaemia associated with an increased mortality rate. The EBI3(-/-) mice displayed an elevated inflammatory immune response with an increased production of T helper type 1 (Th1-), Th2- and Th17-derived cytokines. The increased Th2 immune response appears to have over-ridden the otherwise protective Th1 and Th17 immune responses by the induction of arginase-1-expressing alternatively activated macrophages in these mice. Hence, neutralization of IL-4 and arginase-1 activity partially restored protective immune responses in EBI3(-/-) mice. So far, our results demonstrate that EBI3 is an essential general regulator of inflammatory immune responses in experimental Chagas disease and is required for control of T. cruzi infection by inhibiting Th2-dependent alternative macrophage activation. Further studies are needed to dissect the underlying mechanisms and clarify whether EBI3 association with IL-27 or/and IL-35 accounts for its anti-inflammatory character in parasitic disease.

Indexed as

AnimalsChagas DiseaseDisease Models, AnimalFlow CytometryMacrophage ActivationMiceMice, Inbred C57BLMice, KnockoutMinor Histocompatibility AntigensReal-Time Polymerase Chain ReactionReceptors, CytokineTh17 CellsTh1 CellsTh2 CellsTrypanosoma cruziEbi3 protein, mouseMinor Histocompatibility AntigensReceptors, Cytokinealternative macrophage activationinterleukin-27interleukin-35parasitic infection

Identifiers

PMID26694585
PMCPMC4754611
OpenAlexW2289808877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.